title: Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells.
abstract: 2-chloroadenosine (2-CAdo) is an adenosine deaminase-resistant analogue of adenosine, widely used as an adenosine receptor agonist. This compound has been shown to induce apoptosis in several cell types either via activation of adenosine receptors or via intracellular metabolism. However, the molecular mechanisms of 2-CAdo-induced apoptosis are unclear. Here, we analyzed the effects of 2-CAdo in the leukemia cell line EHEB. 2-CAdo was found to induce apoptosis in EHEB cells, as shown by caspase-3 activation, DNA fragmentation, poly(ADP-ribose) polymerase (PARP) cleavage and phosphatidylserine exposure. Cytotoxicity of 2-CAdo was completely suppressed by 5-iodotubercidin, an adenosine kinase inhibitor, indicating that apoptosis induced by 2-CAdo was the result of its intracellular metabolism. Accordingly, we found that 2-CAdo was efficiently converted into 2-chloroATP. In parallel, a decrease of intracellular ATP concentration as well as a general inhibition of macromolecular synthesis, involving DNA, RNA and protein synthesis, was observed. Moreover, 2-CAdo induced cytochrome c release into the cytosol, indicating activation of the intrinsic pathway of apoptosis. This was found associated with a decline in Mcl-1 protein level and p53-independent. Inhibition of AMP deaminase by coformycin markedly prevented ATP depletion, and also significantly reduced 2-CAdo cytotoxicity and caspase-3 activation. In conclusion, our data show that intracellular metabolism of 2-CAdo can lead to activation of the intrinsic pathway of apoptosis and that ATP depletion, in addition to the accumulation of the triphosphate analogue, contributes to 2-CAdo-induced apoptosis.
authors.affiliation: de Duve Institute, Université catholique de Louvain, B-1200 Brussels, Belgium.
authors.forename: Laurent
authors.initials: L
authors.lastname: Bastin-Coyette
authors.forename: Caroline
authors.initials: C
authors.lastname: Smal
authors.forename: Sabine
authors.initials: S
authors.lastname: Cardoen
authors.forename: Pascale
authors.initials: P
authors.lastname: Saussoy
authors.forename: Eric
authors.initials: E
authors.lastname: Van den Neste
authors.forename: Françoise
authors.initials: F
authors.lastname: Bontemps
mesh_terms: D015762:2-Chloroadenosine / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D006801:Humans; D015448:Leukemia, B-Cell / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology
chemical_list: D015762:2-Chloroadenosine